(Q37355090)

19 August 2017

1 reference

title

Saccharomyces boulardii in childhood (English)

1 reference

19 August 2017

main subject

Saccharomyces boulardii

object named as

Saccharomyces boulardii

1 reference

3

Hania Szajewska

1 reference

19 August 2017

Yvan Vandenplas

1

1 reference

19 August 2017

Oscar Brunser

series ordinal

2

1 reference

19 August 2017

publication date

19 December 2008

1 reference

European Journal of Pediatrics

19 August 2017

published in

1 reference

19 August 2017

volume

168

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

253-265

1 reference

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0879-7

Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0879-7

Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0879-7

Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0879-7

Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0879-7

Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

21 January 2018

1 reference

12 December 2020

Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children

1 reference

12 December 2020

Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children

1 reference

12 December 2020

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria

1 reference

12 December 2020

Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children

1 reference

12 December 2020

Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.

1 reference

12 December 2020

Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.

1 reference

12 December 2020

Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.

1 reference

12 December 2020

Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children

1 reference

12 December 2020

Innate immune recognition

1 reference

12 December 2020

Saccharomyces boulardii fungemia. Apropos of a case

1 reference

12 December 2020

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

1 reference

12 December 2020

Effects of Saccharomyces boulardii in children with acute diarrhoea

1 reference

12 December 2020

Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.

1 reference

12 December 2020

Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole

1 reference

12 December 2020

Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells

1 reference

12 December 2020

Possible role of catheters in Saccharomyces boulardii fungemia

1 reference

12 December 2020

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study

1 reference

12 December 2020

Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.

1 reference

12 December 2020

Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats

1 reference

12 December 2020

Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression

1 reference

12 December 2020

Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.

1 reference

12 December 2020

The effects of Saccharomyces boulardii on bacterial translocation in rats with obstructive jaundice

1 reference

12 December 2020

Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury

1 reference

12 December 2020

Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study

1 reference

12 December 2020

Antibiotic resistance in food lactic acid bacteria--a review

1 reference

12 December 2020

Probiotics in infectious diarrhoea in children: are they indicated?

1 reference

12 December 2020

Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events

1 reference

12 December 2020

Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population

1 reference

12 December 2020

Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study

1 reference

12 December 2020

Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells

1 reference

12 December 2020

[Saccharomyces boulardii fungal sepsis: beware of the yeast]

1 reference

12 December 2020

Saccharomyces boulardiidecreases inflammation and intestinal colonization byCandida albicansin a mouse model of chemically-induced colitis

1 reference

12 December 2020

Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum

1 reference

12 December 2020

Review article: yeast as probiotics -- Saccharomyces boulardii

1 reference

12 December 2020

Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers

1 reference

12 December 2020

Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori

1 reference

12 December 2020

Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains

1 reference

12 December 2020

Disposition kinetics of Saccharomyces boulardii in man and rat.

1 reference

12 December 2020

Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations

1 reference

12 December 2020

Identification and antibiotic susceptibility of bacterial isolates from probiotic products

1 reference

12 December 2020

Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii

1 reference

12 December 2020

European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe

1 reference

12 December 2020

Experimental effects of Saccharomyces boulardii on diarrheal pathogens

1 reference

12 December 2020

Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation

1 reference

12 December 2020

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

1 reference

12 December 2020

Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors.

1 reference

12 December 2020

Saccharomyces cerevisiae fungemia: an emerging infectious disease

1 reference

12 December 2020

Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro

1 reference

12 December 2020

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa

1 reference

12 December 2020

Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii

1 reference

12 December 2020

Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host

1 reference

12 December 2020

Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice

1 reference

12 December 2020

Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections

1 reference

12 December 2020

Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients

1 reference

12 December 2020

Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock.

1 reference

12 December 2020

Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study

1 reference

12 December 2020

Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation.

1 reference

12 December 2020

Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication

1 reference

12 December 2020

[Effects of Saccharomyces boulardii yeast on trophozoites of Entamoeba histolytica in vitro and in cecal amebiasis in young rats]

1 reference

12 December 2020

Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii

1 reference

12 December 2020

The probiotic effect of Saccharomyces boulardii in a pediatric age group

1 reference

12 December 2020

Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy

1 reference

12 December 2020

Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii

1 reference

12 December 2020

Application of the Colon-Simulation Technique for Studying the Effects of Saccharomyces boulardii on Basic Parameters of Porcine Cecal Microbial Metabolism Disturbed by Clindamycin

1 reference

12 December 2020

Saccharomyces boulardii enhances N-terminal peptide hydrolysis in suckling rat small intestine by endoluminal release of a zinc-binding metalloprotease

1 reference

12 December 2020

Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii

1 reference

12 December 2020

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats

1 reference

12 December 2020

Premature stimulation of rat sucrase-isomaltase (SI) by exogenous insulin and the analog B-Asp10 is regulated by a receptor-mediated signal triggering SI gene transcription

1 reference

12 December 2020

Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3',5'-cyclic monophosphate induction in intestinal cells.

1 reference

12 December 2020

Clinical practice. Antibiotic-associated diarrhea

1 reference

12 December 2020

Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells.

1 reference

12 December 2020

10.1007/S00431-008-0879-7

Identifiers

DOI

1 reference

19 August 2017

1 reference